Piroxicam (Veterinary Grade)

Product Overview

Piroxicam is an oxicam-class non-steroidal anti-inflammatory drug (NSAID) for veterinary use. As a long-acting COX inhibitor, it provides sustained anti-inflammatory, analgesic, and antipyretic effects, making it convenient for chronic musculoskeletal conditions in companion animals and horses.

Piroxicam is a non-selective COX inhibitor that reduces prostaglandin synthesis. Its long plasma half-life of approximately 50 hours enables once-daily dosing, distinguishing it from shorter-acting NSAIDs. Used in dogs for osteoarthritis and as adjunctive therapy in certain cancers, and in horses for musculoskeletal inflammation.

Quality Specifications

Purity	As per USP monograph
Residual Solvents	Compliant with ICH Q3C
Heavy Metals	Compliant with pharmacopoeia limits
GMP Status	Manufactured under GMP conditions

Veterinary Applications

• Canine osteoarthritis management: Long-term pain and inflammation control in dogs with degenerative joint disease
• Equine musculoskeletal inflammation: Treatment of inflammatory conditions in horses
• Feline cancer supportive care: Adjunctive anti-inflammatory therapy in feline oncology
• Postoperative pain management in small animals: Analgesic support following surgical procedures
• Bovine lameness and inflammation: Management of inflammatory conditions in cattle